NCT05679635

Brief Summary

This trial evaluates tracheal pressure values in intubated intensive care unit patients during continuous positive airway pressure without any ventilatory support, automatic tube compensation and assisted spontaneous breathing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 28, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2024

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

1.5 years

First QC Date

November 28, 2022

Last Update Submit

May 24, 2024

Conditions

Keywords

tracheal pressureairway pressure

Outcome Measures

Primary Outcomes (1)

  • inspiratory tracheal pressure

    The lowest tracheal pressure value, representing the highest inspiratory effort, will be recorded from the ventilator

    10 minutes after insertion of the tracheal pressure measurement catheter

Secondary Outcomes (4)

  • peak tracheal pressure

    10 minutes after insertion of the tracheal pressure measurement catheter

  • mean tracheal pressure

    10 minutes after insertion of the tracheal pressure measurement catheter

  • inspiratory tracheal pressure during automatic tube compensation (ATC)

    10 minutes after adding ATC

  • inspiratory tracheal pressure during assisted spontaneous breathing (ASB)

    10 minutes after adding ASB

Study Arms (1)

Study participants

OTHER

In intubated patients during CPAP ventilation, a conventional tube adapter (CTA, Ventinova Medical B.V., Eindhoven, The Netherlands) will be connected to the tracheal tube for tracheal pressure measurement. Tracheal pressure measurements will be recorded directly from the respirator Evone (Ventinova Medical B.V., Eindhoven, The Netherlands) three times, as well as the corresponding airway pressure values from the Evita Infinity V500 respirator (Dräger Medical, Lübeck, Germany). Study related time points: T1: 10 minutes after insertion of the conventional tube adapter during CPAP without ventilator support T2: 10 minutes after T1 during CPAP with activated automatic tube compensation (ATC) T3: 10 minutes after T2 during CPAP with assisted spontaneous breathing (ASB) of 4 cmH2O

Device: EvoneDevice: Evita Infinity V500

Interventions

EvoneDEVICE

The conventional tube adapter (CTA) from the Evone ventilator (Ventinova Medical B.V., Eindhoven, The Netherlands), equipped with an tracheal pressure measurement catheter will be connected to the tracheal tube of intubated intensive care unit patients. Subsequently tracheal pressure values will be displayed and recorded from the ventilator.

Study participants

Displayed airway pressure values will be directly recorded from the Evita Infinity V500 ventilator (Dräger Medical, Lübeck, Germany)

Study participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects ≥ 18 years
  • Intubated patient during CPAP without pressure support
  • Informed consent

You may not qualify if:

  • Female subjects known to be pregnant
  • Known participation in another clinical trial
  • Critical pulmonary state (paO2/FiO2 ratio \<100)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Innsbruck

Innsbruck, Tyrol, 6020, Austria

Location

Study Officials

  • Christopher Rugg, MD

    Medical University of Innsbruck, Department of Anesthesiology and Intensive Care Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: prospective, open, clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2022

First Posted

January 11, 2023

Study Start

November 24, 2022

Primary Completion

May 14, 2024

Study Completion

May 14, 2024

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations